NCT07444749
Trillium Validation Study
StatusCompleted
PhaseNot applicable
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 2 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗
Notable Phase changed: Not specified → Not applicable Show 11 more changesShow less
- Primary endpoint(s) modified
- Sponsor changed: [Redacted] to Philips Clinical & Medical Affairs Global
- Results posted: Nov 12, 2026
- Trial status changed: Withheld → Completed
- Enrollment changed: None → 45
- Interventions modified
- Trial arms changed: 0 → 2
- Primary and study completion dates: May 28, 2026
- Start date: Apr 21, 2026
- Study title shortened, about 10 words
- Collaborators expanded, about 5 words
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Median Unintentional Leak
Timeframe: During each approximately 15-day treatment period
Arms and interventions
Trillium Mask first and then AirFit F20 MaskExperimental
Participants will use Trillium for the first treatment period and AirFit F20 for the second treatment period.
AirFit F20 Mask first then Trillium MaskExperimental
Participants will use AirFit F20 for the first treatment period and Trillium for the second treatment period.
Devices: Trillium, AirFit F20
Sites
1 site in 1 country
- Florida Lung and Sleep AssociatesFort Myers, Florida, United States